Heartburn drug Zantac recalled in Canada, U.S. over contamination fears
Health Canada investigating possible presence of cancer-causing chemical
Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination.
The French company Friday joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug.
In September, the U.S. Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and over-the-counter versions of Zantac. The federal agency said consumers could consider taking another heartburn medicine or contact their doctor.
Health Canada also said it was investigating the possible presence of a carcinogen in some ranitidine drugs available by prescription and over-the-counter. The agency issued a precautionary request last month for companies to stop distributing the medication.
Several drugstore chains have already removed Zantac and generic versions from store shelves.
With files from The Canadian Press
Comments
To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.
By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.